Theralase Technologies Inc (TLTFF)

[123414]

Here is Dr. Kulkarni talking about the first trial.
"For the most part I"m running the clinical trials at this institution. One of those clinical trials is the theralase 1433 1b.  So to speak to what Dr. Jewett said, this is a safety trial.

16:04

;


Here is the official title of the 1b safety trial.

Study Type:
Interventional
Study Design:
Intervention Model: Single Group Assignment
Masking: No masking
Primary Purpose: Treatment
Official Title:
A Phase Ib Trial of Intravesical Photodynamic Therapy in Patients With Non-muscle Invasive Bladder Cancer at High Risk of Progression Who Are Refractory to Bacillus Calmette-Guerin Therapy and Who Are Medically Unfit for/Refuse Cystectomy
https://clinicaltrials.gov/ct2/show/NCT03053635?term=1433&rank=1